2008
DOI: 10.1212/01.wnl.0000269792.63927.86
|View full text |Cite
|
Sign up to set email alerts
|

Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation

Abstract: Congenital neuromuscular disease with uniform type 1 fiber (CNMDU1) in 40% of patients is associated with mutations in the C-terminal domain of RYR1, suggesting that CNMDU1 is allelic to central core disease at least in some patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
52
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(52 citation statements)
references
References 37 publications
0
52
0
Order By: Relevance
“…associated with RYR1 myopathies. 3,10 Noncore RYR1-related myopathies may be more frequent than initially thought and are probably underdiagnosed. Amburgey et al 4 stated that 49% of recessive cases in their study (n ¼ 106) were noncore myopathies.…”
Section: Discussionmentioning
confidence: 99%
“…associated with RYR1 myopathies. 3,10 Noncore RYR1-related myopathies may be more frequent than initially thought and are probably underdiagnosed. Amburgey et al 4 stated that 49% of recessive cases in their study (n ¼ 106) were noncore myopathies.…”
Section: Discussionmentioning
confidence: 99%
“…117000) (11), MmD with external ophthalmoplegia (OMIM no. 255320) (12), congenital myopathy with cores and rods (6,7), central nuclear myopathy (13), and neuromuscular disease with uniform type 1 fibers (14). For all of these disorders, Ca 2ϩ dysregulation is a likely primary cause and a common etiology is possible.…”
mentioning
confidence: 99%
“…Central core disease may also be related to RYR1 mutation and is likely to be complicated with MH [26][27][28]. An RYR1 mutation has also been suggested to be involved in CNMDU1 [3]. Therefore, perioperative MH is a concern in patients with suspected CNMDU1, which is another reason that preoperative definite diagnosis by biopsy is essential.…”
Section: Discussionmentioning
confidence: 99%
“…In 1983, Oh and Danon described CNMDU1 as a distinct nonprogressive congenital neuromuscular disease with features of delayed motor development with early onset, mild proximal muscle weakness, hyporeflexia, normal levels of serum muscle enzymes, including creatine kinase (CK), uniform type 1 fibers, and nonprogression of the disease course [2]. The etiology is unknown, but mutation of the ryanodine receptor gene one (RYR1) may be involved in CNMDU1 [3].…”
Section: Introductionmentioning
confidence: 99%